Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 20, 2016 CD
Six back issues from 2016 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 20 No. 1 January/February 2016 Volume 20, Number 1
Vol. 20 No. 2 March/April 2016 Volume 20, Number 2
Vol. 20 No. 3 May/June 2016 Volume 20, Number 3
Vol. 20 No. 4 July/August 2016 Volume 20, Number 4
Vol. 20 No. 5 September/October 2016 Volume 20, Number 5
Vol. 20 No. 6 November/December 2016 Volume 20, Number 6

Volume 20, 2016 CD ARTICLES

Volume20, 2016 CD ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: Starting Year 20! Vol. 20 No. 1 4
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Vol. 20 No. 1 6
Microbial Identification in Pharmaceutical Compounding Vol. 20 No. 1 13
Basic Principles of Lyophilization, Part 2 Vol. 20 No. 1 20
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success Vol. 20 No. 1 29
Formulation and Stability of Solutions Vol. 20 No. 1 41
Calculations Vol. 20 No. 1 46
Aprepitant 80-mg Capsules Vol. 20 No. 1 48
Aripiprazole 10-mg Oral Dissolving Tablets Vol. 20 No. 1 49
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Vol. 20 No. 1 50
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Vol. 20 No. 1 51
Mupirocin Calcium 2% Cream Vol. 20 No. 1 52
Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream Vol. 20 No. 1 53
Thrombin 1,000 Units/mL Topical Solution, Sterile Vol. 20 No. 1 54
Tropicamide 1% Ophthalmic Solution Vol. 20 No. 1 55
Vancomycin 5% and Amikacin 2% Ophthalmic Solution Vol. 20 No. 1 56
Voriconazole 10-mg/mL Ophthalmic Solution Vol. 20 No. 1 57
Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care Vol. 20 No. 1 58
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation Vol. 20 No. 1 63
A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis Vol. 20 No. 1 71
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date Vol. 20 No. 1 81
PostScription: The Home Field Advantage Vol. 20 No. 1 86
PreScription: Compounding: A Changing Paradigm Vol. 20 No. 2 92
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations Vol. 20 No. 2 95
Root Cause Analysis, Part 2: Sterile Compounding Vol. 20 No. 2 99
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Vol. 20 No. 2 107
Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives Vol. 20 No. 2 114
Basics of Compounding: Capsules Vol. 20 No. 2 125
Formulation and Stability of Solutions Vol. 20 No. 2 137
Calculations Vol. 20 No. 2 142
Blue Goo Anti-Itch Gel Vol. 20 No. 2 144
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Vol. 20 No. 2 145
Medicated Polyox Bandage for Skin Ulcers Vol. 20 No. 2 146
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Vol. 20 No. 2 147
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) Vol. 20 No. 2 148
Utilization of Compounded Medications in an Oral Medicine Practice Vol. 20 No. 2 155
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups Vol. 20 No. 2 159
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Vol. 20 No. 2 164
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Vol. 20 No. 2 167
PreScription: Patient Access to Pharmaceuticals Vol. 20 No. 3 180
Current Perspectives on the Syringe Delivery System Vol. 20 No. 3 182
Compounding in Nigeria Vol. 20 No. 3 189
IACP Names Voliva Executive Vice President Vol. 20 No. 3 194
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Vol. 20 No. 3 197
Does Your Drug Expertise Include Clinical Pharmaceutics? Vol. 20 No. 3 202
Basics of Compounding: Special Capsules Vol. 20 No. 3 209
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Vol. 20 No. 3 217
Calculations Vol. 20 No. 3 224
Carboplatin 50-mg/mL Injection Vol. 20 No. 3 226
Cefotetan Disodium Injection Vol. 20 No. 3 227
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Vol. 20 No. 3 228
Dexpanthenol 5% Nasal Spray Vol. 20 No. 3 229
Indomethacin Gel Vol. 20 No. 3 230
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Vol. 20 No. 3 231
Montelukast Sodium 5-mg Fast-Dissolving Film Vol. 20 No. 3 232
Pain-Away II Headache Capsules Vol. 20 No. 3 233
Sodium Nitroprusside 25-mg/mL Injection Vol. 20 No. 3 234
Zolpidem Tartrate 5-mg and 10-mg Capsules Vol. 20 No. 3 235
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Vol. 20 No. 3 236
Topical Metered-dosing Dispenser Performance Evaluation Vol. 20 No. 3 239
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Vol. 20 No. 3 247
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Vol. 20 No. 3 250
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Vol. 20 No. 3 257
PostScription: Supporting Your Alma Mater: Whose World Will You Change? Vol. 20 No. 3 262
PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing? Vol. 20 No. 4 268
Compounding Transdermal Medication for Feline Patients Vol. 20 No. 4 271
Case Report: Pediatric Scar Management After Open-heart Surgery Vol. 20 No. 4 277
Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Vol. 20 No. 4 283
IACP's 2016 Compounders on Capitol Hill Asks Vol. 20 No. 4 294
Basics of Compounding: Compounding Films Vol. 20 No. 4 298
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Vol. 20 No. 4 307
Calculations Vol. 20 No. 4 316
Dolasetron Mesylate 20-mg/mL Injection Vol. 20 No. 4 318
Gatifloxacin 0.5% Ophthalmic Solution Vol. 20 No. 4 319
Mebendazole 100-mg Capsules Vol. 20 No. 4 320
Neomycin Sulfate 25-mg/mL Oral Solution Vol. 20 No. 4 321
Nystatin 100,000-units Vaginal Inserts Vol. 20 No. 4 322
1,2-Octanediol 5% Topical Liquid Vol. 20 No. 4 323
Phytonadione 1-mg/mL Oral Solution Vol. 20 No. 4 324
Plasmingen and Hyaluronate Sodium Ophthalmic Solution Vol. 20 No. 4 325
Scopolamine Hydrobromide 0.25% Ophthalmic Solution Vol. 20 No. 4 326
Tretinoin 10-mg Oral Capsules Vol. 20 No. 4 327
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Vol. 20 No. 4 328
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations Vol. 20 No. 4 333
Stability of Ampicillin in Normal Saline and Buffered Normal Saline Vol. 20 No. 4 338
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump Vol. 20 No. 4 343
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product Vol. 20 No. 4 347
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Vol. 20 No. 4 351
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Vol. 20 No. 5 356
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Vol. 20 No. 5 359
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Vol. 20 No. 5 367
More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard! Vol. 20 No. 5 377
Quality Control Analytical Methods: Method Validation Vol. 20 No. 5 381
Basics of Compounding: Clinical Pharmaceutics, Part 1 Vol. 20 No. 5 389
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Vol. 20 No. 5 399
Calculations Vol. 20 No. 5 405
Clobazam 1-mg/mL Oral Suspension Vol. 20 No. 5 406
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base Vol. 20 No. 5 407
Inamrinone 5-mg/mL Injection Vol. 20 No. 5 408
Levetiracetam 50-mg/mL Oral Suspension Vol. 20 No. 5 409
Naproxen 5% Cream Vol. 20 No. 5 410
Permethrin 1% Lotion Vol. 20 No. 5 411
Progesterone 10% Cream Vol. 20 No. 5 412
Sodium Phosphate Oral Solution Vol. 20 No. 5 413
Tetracaine Hydrochloride 2% Topical Solution Vol. 20 No. 5 414
Tromethamine Injection Vol. 20 No. 5 415
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product Vol. 20 No. 5 416
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt Vol. 20 No. 5 421
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Vol. 20 No. 5 426
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light Vol. 20 No. 5 435
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution Vol. 20 No. 5 438
PreScription: Two Decades of IJPC Vol. 20 No. 6 444
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Vol. 20 No. 6 447
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Vol. 20 No. 6 457
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy Vol. 20 No. 6 461
Why Become Pharmacy Compounding Accreditation Board Accredited? Vol. 20 No. 6 469
The "Lists": What Do They Mean? Vol. 20 No. 6 477
Introduction to Quality Control in a Compounding Pharmacy Vol. 20 No. 6 481
Basics of Compounding: Clinical Pharmaceutics, Part 2 Vol. 20 No. 6 485
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Vol. 20 No. 6 495
Calculations Vol. 20 No. 6 502
Alendronate 70-mg/75-mL Drinkable Formulation Vol. 20 No. 6 504
Bosentan 6.25-mg/mL Oral Suspension Vol. 20 No. 6 505
Capsaicin 0.025% and Doxepin 3.3% Cream Vol. 20 No. 6 506
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel Vol. 20 No. 6 507
Erlotinib 10-mg/mL Oral Suspension Vol. 20 No. 6 508
Flumazenil 0.1-mg/mL Injection Vol. 20 No. 6 509
Imatinib 40-mg/mL Oral Suspension Vol. 20 No. 6 510
Lapatinib Ditosylate 50-mg/mL Oral Suspension Vol. 20 No. 6 511
Melatonin 2-mg/mL Oral Suspension Vol. 20 No. 6 512
Menthol, Chloral Hydrate, and Camphor Analgesic Ointment Vol. 20 No. 6 513
Stability of Fentanyl Citrate in Polyolefin Bags Vol. 20 No. 6 514
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Vol. 20 No. 6 517
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature Vol. 20 No. 6 521
PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution Vol. 20 No. 6 526